Quantinno Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,800
Closed -$4.08M 3349
2025
Q4
$4.08M Buy
+3,800
New +$3.63M 0.01% 1107
2025
Q3
Sell
-4,500
Closed -$3.51M 2981
2025
Q2
$3.51M Buy
+4,500
New +$3.5M 0.02% 938

Other funds holding LLY

Quantinno Capital Management's LLY Position: Q1 2026 in Review

Quantinno Capital Management increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $64.9M and bringing the position to 433,880 shares worth $399M. The position accounts for 0.67% of the portfolio, ranked #15.

Quantinno Capital Management first reported a position in LLY in Q4 2018 and has held it in 21 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quantinno Capital Management held 433,880 shares of Eli Lilly worth $399M as of Q1 2026.
  • Quantinno Capital Management bought 64,039 Eli Lilly shares in Q1 2026, an estimated $64.9M.
  • Eli Lilly made up 0.67% of Quantinno Capital Management's portfolio in Q1 2026, its #15 holding.
  • Quantinno Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 21 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.